Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia
Primary Purpose
Obesity, Adolescent, Oxidative Stress
Status
Completed
Phase
Phase 4
Locations
Indonesia
Study Type
Interventional
Intervention
Vitamin E 400 UNT
Placebo oral capsule
Sponsored by
About this trial
This is an interventional treatment trial for Obesity, Adolescent
Eligibility Criteria
Inclusion Criteria:
- Obesity BMI ≥ p95 (CDC growth curve)
Exclusion Criteria:
- Consuming antioxidants drug regularly within recruiting time
- Consuming Orlistat
Sites / Locations
- SMA Labschool
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Vitamin E 400 IU
Placebo
Arm Description
Vitamin-E Capsule (alpha-tocopherol) 400 IU once per day orally for 8 weeks
Placebo capsule once per day orally for 8 weeks
Outcomes
Primary Outcome Measures
Isoprostane (oxidative stress)
pg/ml
Secondary Outcome Measures
Total Cholesterol
mg/dl
LDL Cholesterol
mg/dl
HDL Cholesterol
mg/dl
Triglycerides
mg/dl
Body weight
kilograms
Body Height
centimeters
BMI
kg/m^2
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03358524
Brief Title
Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia
Official Title
Effects of Vitamin E (Alfa-Tocoferol) Supplementation on Isoprostane and Lipid Profile of Obese Adolescent in Jakarta, Indonesia
Study Type
Interventional
2. Study Status
Record Verification Date
March 2018
Overall Recruitment Status
Completed
Study Start Date
September 28, 2017 (Actual)
Primary Completion Date
February 20, 2018 (Actual)
Study Completion Date
March 1, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Indonesia University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study evaluate supplementation of vitamin E (alpha-tocopherol) in obese adolescent. Half of the patient will receive vitamin E and the other half received placebo
Detailed Description
One of obesity treatments that play important role is antioxidant diet. The effects of vitamin E supplementation as an antioxidant treatment in obese adolescent have not been concluded yet in Indonesia. The primary aim of this study is to observe oxidative stress biomarker (isoprostane) in obese teenagers who consume vitamin E for 2 months. The secondary aim is to observe their body mass index and lipid profile after supplementation
The study is randomized, double blind, placebo controlled trial in design and employed a consecutive sampling technique to sample subjects of 70 obese adolescent age 14 - 18 in senior high schools Jakarta.
Blood tests of lipid profile (total cholesterol, HDL, LDL, Triglyceride), fasting blood glucose, liver function (AST,ALT) and oxidative stress biomarker (isoprostane) were taken for every subject after done fasting for 12 hours.
This study is a randomized allocation and double blind technique. subjects divided into two groups, which one group receiving treatment of vitamin E and other group receiving placebo.
The dose and duration of vitamin E treatment is 400 IU per day for 2 months. At the end of treatment, all subjects had to run the same medical interview, physical examination and blood test.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Adolescent, Oxidative Stress
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
69 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Vitamin E 400 IU
Arm Type
Experimental
Arm Description
Vitamin-E Capsule (alpha-tocopherol) 400 IU once per day orally for 8 weeks
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo capsule once per day orally for 8 weeks
Intervention Type
Drug
Intervention Name(s)
Vitamin E 400 UNT
Other Intervention Name(s)
Vitamin E
Intervention Description
Vitamin-E capsule (alpha tocopherol) 400 IU (once per day)
Intervention Type
Drug
Intervention Name(s)
Placebo oral capsule
Other Intervention Name(s)
Placebo
Intervention Description
sugar capsule manufactured to mimic vitamin E capsule once per day
Primary Outcome Measure Information:
Title
Isoprostane (oxidative stress)
Description
pg/ml
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Total Cholesterol
Description
mg/dl
Time Frame
8 weeks
Title
LDL Cholesterol
Description
mg/dl
Time Frame
8 weeks
Title
HDL Cholesterol
Description
mg/dl
Time Frame
8 weeks
Title
Triglycerides
Description
mg/dl
Time Frame
8 weeks
Title
Body weight
Description
kilograms
Time Frame
8 weeks
Title
Body Height
Description
centimeters
Time Frame
8 weeks
Title
BMI
Description
kg/m^2
Time Frame
8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Obesity BMI ≥ p95 (CDC growth curve)
Exclusion Criteria:
Consuming antioxidants drug regularly within recruiting time
Consuming Orlistat
Facility Information:
Facility Name
SMA Labschool
City
Jakarta
ZIP/Postal Code
13220
Country
Indonesia
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia
We'll reach out to this number within 24 hrs